0 NASDAQ Companies - March 4, 2019Strongbridge Biopharma plc Announces Upcoming Presentation of New Data from Phase 3 SONICS Study of RECORLEV™ (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome at the 2019 Annual Meeting of the Endocrine Society (ENDO)Read More
0 NASDAQ Companies - March 4, 2019Agile Therapeutics Announces $7.8 Million Private PlacementRead More
0 NASDAQ Companies - March 4, 2019Translate Bio to Present at the 39th Annual Cowen and Company Healthcare ConferenceRead More
0 TSX Venture News - March 4, 2019U.S. Hemp Legalization Expands Market for FluroTech’s CompleTest™Read More
0 TSX Venture News - March 4, 2019RETRANSMISSION – Serengeti Expands Kwanika Central Zone Mineral Resource – Project Confidence Substantially IncreasedRead More
0 NYSE Companies - March 4, 2019Denbury and Penn Virginia Announce Filing of Definitive Proxy MaterialsRead More
0 NASDAQ Companies - March 4, 2019Clearside Biomedical to Present at the Cowen and Company 39th Annual Health Care ConferenceRead More
0 NASDAQ Companies - March 4, 2019Calithera Biosciences to Report Fourth Quarter 2018 Financial Results on Thursday, March 7, 2019Read More
0 NASDAQ Companies - March 4, 2019BioCryst Reports Fourth Quarter and Full Year 2018 Financial ResultsRead More
